Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 2 1Phase 1 1

Status

Unknown 2Completed 2Not yet recruiting 1

Sponsor Class

OTHER 4OTHER_GOV 1

Study Type

Interventional 5

Sponsor

Conditions

Warts 4Torulopsis 1Condylomata Acuminata 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
PRA1 protein, Candida albicans × Clear all
NCT06749665 2024-12-27

Sclerotherapy and Candida Antigen in Treatment of Common Warts

Sohag University

Phase NA Not yet recruiting
75 enrolled

Warts

NCT04399577 2020-05-27

Complement Component 3c and Tumor Necrosis Factor-α in Patients With Human Papillomavirus-Induced Cutaneous Warts

Zagazig University

Phase 2 Completed
39 enrolled

Warts

NCT03853785 2019-03-12

Efficacy of Intralesional MMR Vaccine,Intralesional Candidal Antigen&Topical Podophyllin in Treatment of Genital Warts

Assiut University

Phase 3 Unknown
45 enrolled

Condylomata Acuminata

NCT03158168 2018-07-24

Intralesional Candidal Antigen Versus Intralesional Zinc Sulphate in Treatment of Cutaneous Warts

Assiut University

Phase 3 Unknown
70 enrolled

Warts

NCT00569231 2011-01-25

Study With Candida Antigen for Treatment of Warts

University of Arkansas

Phase 1 Completed
18 enrolled 8 charts

Torulopsis, Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡